Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
127.74
+0.62 (0.49%)
At close: Nov 12, 2024, 4:00 PM
128.10
+0.36 (0.28%)
Pre-market: Nov 13, 2024, 5:43 AM EST

Jazz Pharmaceuticals Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for JAZZ stock have an average target of 173.57, with a low estimate of 113 and a high estimate of 230. The average target predicts an increase of 35.88% from the current stock price of 127.74.

Analyst Consensus: Buy
Target Low Average Median High
Price $113 $173.57 $179 $230
Change -11.54% +35.88% +40.13% +80.05%

Analyst Ratings

The average analyst rating for JAZZ stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 665555
Buy 777666
Hold 334433
Sell 000000
Strong Sell 000000
Total 161616151414

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Reiterates
$207
Strong Buy Reiterates $207 +62.05% Nov 7, 2024
RBC Capital
RBC Capital
Buy
Maintains
$175$179
Buy Maintains $175$179 +40.13% Oct 23, 2024
RBC Capital
RBC Capital
Buy
Maintains
$174$175
Buy Maintains $174$175 +37.00% Oct 4, 2024
Needham
Needham
Strong Buy
Reiterates
$205
Strong Buy Reiterates $205 +60.48% Sep 10, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$140
Buy Reiterates $140 +9.60% Sep 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
4.12B
from 3.83B
Increased by 7.43%
Revenue Next Year
4.38B
from 4.12B
Increased by 6.39%
EPS This Year
20.57
from 6.10
Increased by 237.12%
EPS Next Year
22.15
from 20.57
Increased by 7.70%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
2.16B2.36B3.09B3.66B3.83B4.12B4.38B4.58B
Revenue Growth
14.32%9.34%30.91%18.26%4.78%7.43%6.39%4.54%
EPS
9.094.22-5.52-3.586.1020.5722.1523.13
EPS Growth
24.52%-53.58%---237.12%7.70%4.41%
Forward PE
-----6.215.775.52
No. Analysts -----222220
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 4.3B 4.8B 5.2B
Avg 4.1B 4.4B 4.6B
Low 3.9B 3.9B 4.0B

Revenue Growth

Revenue Growth 20242025202620272028
High
11.4%
16.1%
19.8%
Avg
7.4%
6.4%
4.5%
Low
2.3%
-6.1%
-9.4%

EPS Forecast

EPS 20242025202620272028
High 21.59 25.45 26.54
Avg 20.57 22.15 23.13
Low 18.83 15.10 16.52

EPS Growth

EPS Growth 20242025202620272028
High
253.8%
23.7%
19.8%
Avg
237.1%
7.7%
4.4%
Low
208.5%
-26.6%
-25.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.